Dermatology & Skin Health
Dermatology
Skin conditions affect millions worldwide, impacting both health and quality of life. CenExel is committed to advancing dermatology research by partnering with sponsors to deliver innovative treatments across a wide range of skin diseases — from common conditions to complex and rare disorders.



Leading Dermatology Clinical Research
Complex dermatology trials require specialized expertise and patient-focused care. CenExel’s research teams include experienced dermatologists, clinical investigators, and operational experts — ensuring efficient trial execution from recruitment through completion.
We support early and late-phase dermatology studies with advanced methodologies, precise endpoint tracking, and high-quality data delivery.
Our dermatology sites cover a broad spectrum of conditions including inflammatory skin diseases, autoimmune disorders, and rare dermatologic conditions — across pediatric, adult, and geriatric populations.
Dermatologic Conditions We Research
Our dermatology research sites support a broad spectrum of conditions—from common skin disorders to complex and rare dermatologic diseases.
Psoriasis
Atopic Dermatitis (Eczema)
Acne Vulgaris
Rosacea
Vitiligo
Hidradenitis Suppurativa
Alopecia Areata
Chronic Urticaria
Contact Dermatitis
Pruritus (Chronic Itching)
Why Sponsors Choose CenExel for Dermatology
Our dermatology expertise goes beyond patient enrollment—we deliver specialized scientific insight, efficient study execution, and high-quality data to support regulatory success.
01
Expert Dermatology Teams
Our investigators and raters ensure accurate diagnosis, consistent assessments, and high-quality data across all dermatology trials.
02
Advanced Imaging & Biomarkers
We utilize cutting-edge imaging tools and biomarker strategies to enhance study precision and accelerate decision-making.
03
Diverse Patient Access
Access to broad and diverse patient populations enables faster recruitment and more representative study outcomes.
04
Efficient Enrollment
Our recruitment strategies consistently achieve strong enrollment rates, reducing study timelines and improving efficiency.
Supported Trial Phases
CenExel supports dermatology trials across all phases — from early-stage safety and proof-of-concept studies to large-scale Phase III and post-marketing trials.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
Therapeutic Area
ENT Clinical Research
ENT disorders impact millions worldwide, affecting breathing, hearing, and quality of life.
Therapeutic Area
Gastroenterology
In the U.S., millions of patients are affected by gastrointestinal disorders, ranging from chronic conditions like IBS and IBD
Therapeutic Area
Neurology
Neurological disorders affect millions worldwide, creating a critical need for innovative research and advanced treatments.
